MiniMed director Kevin E. Lofton acquires 836 shares

MiniMed completed an exchange offer of up to an aggregate of 252,813,348 newly issued common shares in exchange for Medtronic ordinary shares.

Rhea-AI Filing Summary

Kevin E. Lofton reported acquisition or exercise transactions in this Form 4 filing. MiniMed Group, Inc. issued 836 common shares to director Kevin E. Lofton on October 15, 2026, in exchange for 182 Medtronic plc ordinary shares accepted in the completed exchange offer. The final exchange ratio was 4.5939 MiniMed common shares for each accepted Medtronic ordinary share. Lofton’s resulting MiniMed holdings were 40,409 shares, including shares to be issued in connection with vesting of one or more restricted stock units.

Insider Trade Summary

Grant/Award: 836 shares

Grant/Award 1 txn

Insider Lofton Kevin E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1, F2	836	--	--

Holdings After Transaction: Common Stock — 40,409 shares (Direct)

Footnotes (2)

1. F1. On October 15, 2026, MiniMed Group, Inc. ("MiniMed") issued shares of its common stock to the Reporting Person in connection with the completion of an exchange offer of up to an aggregate of 252,813,348 newly issued shares of common stock of MiniMed in exchange for outstanding ordinary shares of Medtronic plc ("Medtronic"). The final exchange ratio was 4.5939 shares of MiniMed common stock for each ordinary share of Medtronic accepted in the exchange offer. As a result, the Reporting Person received 836 shares of MiniMed common stock in exchange for 182 ordinary shares of Medtronic accepted in the exchange offer.
2. F2. Includes shares of common stock to be issued in connection with the vesting of one or more restricted stock units.

Key Figures

MiniMed common shares received: 836 shares Medtronic ordinary shares exchanged: 182 shares Final exchange ratio: 4.5939 MiniMed common shares per Medtronic ordinary share +2 more

5 metrics

MiniMed common shares received 836 shares Kevin E. Lofton received these on October 15, 2026, in exchange for Medtronic plc ordinary shares.

Medtronic ordinary shares exchanged 182 shares Accepted in the exchange offer for Kevin E. Lofton’s MiniMed shares on October 15, 2026.

Final exchange ratio 4.5939 MiniMed common shares per Medtronic ordinary share Applied to Medtronic ordinary shares accepted in the exchange offer.

MiniMed shares held following transaction 40,409 shares Kevin E. Lofton’s holdings; includes shares to be issued in connection with vesting of one or more restricted stock units.

Exchange-offer share amount Up to an aggregate of 252,813,348 newly issued common shares MiniMed shares offered in exchange for outstanding Medtronic plc ordinary shares.

Key Terms

exchange offer, exchange ratio, ordinary shares, restricted stock units

4 terms

exchange offer financial

"completion of an exchange offer for outstanding ordinary shares of Medtronic plc"

An exchange offer is a proposal where a company asks investors to swap existing securities, like bonds or shares, for new ones, often with different terms or maturity dates. It matters to investors because it can affect the value of their holdings and the company's financial strategy, potentially providing benefits like better interest rates or reduced debt.

exchange ratio financial

"The final exchange ratio was 4.5939 shares of MiniMed common stock"

The exchange ratio is the number used to decide how many shares of one company you get for each share you own in another company during a merger or acquisition. It’s like a recipe that tells you how to swap shares fairly, ensuring both companies’ values are balanced. This ratio matters because it determines how ownership divides between the companies' shareholders.

ordinary shares financial

"outstanding ordinary shares of Medtronic plc"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

restricted stock units technical

"vesting of one or more restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MMED shares did Kevin E. Lofton receive?

Director Kevin E. Lofton received 836 MiniMed common shares on October 15, 2026, in exchange for 182 Medtronic plc ordinary shares accepted in the exchange offer.

What was the exchange ratio for MiniMed’s exchange offer?

The final exchange ratio was 4.5939 MiniMed common shares for each Medtronic plc ordinary share accepted.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/19/2026 - 06:51 PM EDT Accepted by SEC EDGAR 10/19/2026 - 06:51 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lofton Kevin E

(Last) (First) (Middle)

C/O MINIMED GROUP, INC.

18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CALIFORNIA 91325

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2026		A		836(1)	A	(1)	40,409(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On October 15, 2026, MiniMed Group, Inc. ("MiniMed") issued shares of its common stock to the Reporting Person in connection with the completion of an exchange offer of up to an aggregate of 252,813,348 newly issued shares of common stock of MiniMed in exchange for outstanding ordinary shares of Medtronic plc ("Medtronic"). The final exchange ratio was 4.5939 shares of MiniMed common stock for each ordinary share of Medtronic accepted in the exchange offer. As a result, the Reporting Person received 836 shares of MiniMed common stock in exchange for 182 ordinary shares of Medtronic accepted in the exchange offer.

2. Includes shares of common stock to be issued in connection with the vesting of one or more restricted stock units.

Remarks:

	/s/ Bryan F. Kelly, attorney-in-fact	10/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)